BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 25384406)

  • 21. Effect of DJ-1 overexpression on the proliferation, apoptosis, invasion and migration of laryngeal squamous cell carcinoma SNU-46 cells through PI3K/AKT/mTOR.
    Wang B; Qin H; Wang Y; Chen W; Luo J; Zhu X; Wen W; Lei W
    Oncol Rep; 2014 Sep; 32(3):1108-16. PubMed ID: 24969178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DJ-1 is involved in the peritoneal metastasis of gastric cancer through activation of the Akt signaling pathway.
    Zhu ZM; Li ZR; Huang Y; Yu HH; Huang XS; Yan YF; Shao JH; Chen HP
    Oncol Rep; 2014 Mar; 31(3):1489-97. PubMed ID: 24398929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of connective tissue growth factor overexpression decreases growth of hepatocellular carcinoma cells in vitro and in vivo.
    Jia XQ; Cheng HQ; Li H; Zhu Y; Li YH; Feng ZQ; Zhang JP
    Chin Med J (Engl); 2011 Nov; 124(22):3794-9. PubMed ID: 22340243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LINC01133 aggravates the progression of hepatocellular carcinoma by activating the PI3K/AKT pathway.
    Zheng YF; Zhang XY; Bu YZ
    J Cell Biochem; 2019 Mar; 120(3):4172-4179. PubMed ID: 30548306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 3'3-Diindolylmethane inhibits migration, invasion and metastasis of hepatocellular carcinoma by suppressing FAK signaling.
    Li WX; Chen LP; Sun MY; Li JT; Liu HZ; Zhu W
    Oncotarget; 2015 Sep; 6(27):23776-92. PubMed ID: 26068982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting EMP3 suppresses proliferation and invasion of hepatocellular carcinoma cells through inactivation of PI3K/Akt pathway.
    Hsieh YH; Hsieh SC; Lee CH; Yang SF; Cheng CW; Tang MJ; Lin CL; Lin CL; Chou RH
    Oncotarget; 2015 Oct; 6(33):34859-74. PubMed ID: 26472188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted inhibition of ACK1 can inhibit the proliferation of hepatocellular carcinoma cells through the PTEN/AKT/mTOR pathway.
    Wang B; Song K; Chen L; Su H; Gao L; Liu J; Huang A
    Cell Biochem Funct; 2020 Jul; 38(5):642-650. PubMed ID: 32162707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway.
    Zhang DM; Liu JS; Deng LJ; Chen MF; Yiu A; Cao HH; Tian HY; Fung KP; Kurihara H; Pan JX; Ye WC
    Carcinogenesis; 2013 Jun; 34(6):1331-42. PubMed ID: 23393227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The positive correlation between DJ-1 and β-catenin expression shows prognostic value for patients with glioma.
    Wang C; Fang M; Zhang M; Li W; Guan H; Sun Y; Xie S; Zhong X
    Neuropathology; 2013 Dec; 33(6):628-36. PubMed ID: 23714193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FAM9C plays an anti-apoptotic role through activation of the PI3K/Akt pathway in human hepatocellular carcinoma.
    Zhou JD; Shen F; Ji JS; Zheng K; Huang M; Wu JC
    Oncol Rep; 2013 Sep; 30(3):1275-84. PubMed ID: 23836295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of phosphatase and tensin homolog enhances cell invasion and migration through AKT/Sp-1 transcription factor/matrix metalloproteinase 2 activation in hepatocellular carcinoma and has clinicopathologic significance.
    Sze KM; Wong KL; Chu GK; Lee JM; Yau TO; Ng IO
    Hepatology; 2011 May; 53(5):1558-69. PubMed ID: 21520171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knockdown of FOXK1 inhibited the proliferation, migration and invasion in hepatocellular carcinoma cells.
    Li P; Yu Z; He L; Zhou D; Xie S; Hou H; Geng X
    Biomed Pharmacother; 2017 Aug; 92():270-276. PubMed ID: 28551547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ribonucleotide reductase M2B inhibits cell migration and spreading by early growth response protein 1-mediated phosphatase and tensin homolog/Akt1 pathway in hepatocellular carcinoma.
    Tian H; Ge C; Li H; Zhao F; Hou H; Chen T; Jiang G; Xie H; Cui Y; Yao M; Li J
    Hepatology; 2014 Apr; 59(4):1459-70. PubMed ID: 24214128
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Li GM; Liang CJ; Zhang DX; Zhang LJ; Wu JX; Xu YC
    Chin Med J (Engl); 2018 Oct; 131(19):2320-2331. PubMed ID: 30246718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Silencing GTSE-1 expression inhibits proliferation and invasion of hepatocellular carcinoma cells.
    Guo L; Zhang S; Zhang B; Chen W; Li X; Zhang W; Zhou C; Zhang J; Ren N; Ye Q
    Cell Biol Toxicol; 2016 Aug; 32(4):263-74. PubMed ID: 27240802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DJ-1, a novel regulator of the tumor suppressor PTEN.
    Kim RH; Peters M; Jang Y; Shi W; Pintilie M; Fletcher GC; DeLuca C; Liepa J; Zhou L; Snow B; Binari RC; Manoukian AS; Bray MR; Liu FF; Tsao MS; Mak TW
    Cancer Cell; 2005 Mar; 7(3):263-73. PubMed ID: 15766664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of the proliferation and invasion of hepatocellular carcinoma cells by lipocalin 2 through blockade of JNK and PI3K/Akt signaling.
    Lee EK; Kim HJ; Lee KJ; Lee HJ; Lee JS; Kim DG; Hong SW; Yoon Y; Kim JS
    Int J Oncol; 2011 Feb; 38(2):325-33. PubMed ID: 21132267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rap2B knockdown suppresses malignant progression of hepatocellular carcinoma by inactivating the PTEN/PI3K/Akt and ERK1/2 pathways.
    Zhu L; Sun Y; Zhang S; Wang L
    Mol Cell Biochem; 2020 Mar; 466(1-2):55-63. PubMed ID: 32052247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis.
    Zhao J; Chen X; Lin W; Wu G; Zhuang Q; Zhong X; Hong Z; Peng J
    Int J Oncol; 2013 Mar; 42(3):971-8. PubMed ID: 23338043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Knockdown of the Sonic Hedgehog (SHH) Gene Inhibits Proliferation of Hep3B and SMMC-7721 Hepatocellular Carcinoma Cells via the PI3K/Akt/PCK1 Signaling Pathway.
    Chen Y; Zhu W
    Med Sci Monit; 2019 Aug; 25():6023-6033. PubMed ID: 31406102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.